1887

Abstract

In human cytomegalovirus (HCMV) infection, the isolated expression of the viral immediate-early protein 2 (IE2) 86 kDa regulatory protein coincides with an up-regulation of cyclin E gene expression, both in fibroblasts and U373 cells. Since IE2 also interferes with cell-cycle progression, it is unclear whether IE2 is a genuine activator of cyclin E or whether IE2-arrested cells contain elevated levels of cyclin E primarily as a consequence of them being arrested at the beginning of S phase. It is important to distinguish between these possibilities in order to define and analyse at a mechanistic level the proliferative and anti-proliferative capacities of IE2. Here we have shown that IE2 can activate cyclin E independent of the cell-cycle state and can therefore function as a genuine activator of cyclin E gene expression. A mutant of IE2 that failed to activate cyclin E also failed to promote G/S transition. Instead, cells became arrested in G. S-phase entry could be rescued in these cells by co-expression of cyclin E, but these cells still arrested in early S phase, as is the case with wild-type IE2. Our data demonstrate that IE2 can promote two independent cell-cycle functions at the same time: (i) the induction of G/S transition via up-regulation of cyclin E, and (ii) a block in cell-cycle progression in early S phase. In G, the proliferative activity of IE2 appears to be dominant over the anti-proliferative force, whereas after G/S transition, this situation is reversed.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.18702-0
2003-01-01
2024-04-25
Loading full text...

Full text loading...

/deliver/fulltext/jgv/84/1/vir840051.html?itemId=/content/journal/jgv/10.1099/vir.0.18702-0&mimeType=html&fmt=ahah

References

  1. Adams P. D., Lopez P., Sellers W. R., Kaelin W. G. Jr 1997; Fluorescence-activated cell sorting of transfected cells. Methods Enzymol 283:59–72
    [Google Scholar]
  2. Bartek J., Lukas J. 2001; Pathways governing G1/S transition and their response to DNA damage. FEBS Lett 490:117–122
    [Google Scholar]
  3. Biron K. K., Fyfe J. A., Stanat S. C., Leslie L. K., Sorrell J. B., Lambe C. U., Coen D. M. 1986; A human cytomegalovirus mutant resistant to the nucleoside analog 9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine (BW B759U) induces reduced levels of BW B759U triphosphate. Proc Natl Acad Sci U S A 83:8769–8773
    [Google Scholar]
  4. Bresnahan W. A., Boldogh I., Thompson E. A., Albrecht T. 1996; Human cytomegalovirus inhibits cellular DNA synthesis and arrests productively infected cells in late G1. Virology 224:150–160
    [Google Scholar]
  5. Bresnahan W. A., Boldogh I., Chi P., Thompson E. A., Albrecht T. 1997a; Inhibition of cellular Cdk2 activity blocks human cytomegalovirus replication. Virology 231:239–247
    [Google Scholar]
  6. Bresnahan W. A., Thompson E. A., Albrecht T. 1997b; Human cytomegalovirus infection results in altered Cdk2 subcellular localization. J Gen Virol 78:1993–1997
    [Google Scholar]
  7. Bresnahan W. A., Albrecht T., Thompson E. A. 1998; The cyclin E promoter is activated by human cytomegalovirus 86-kDa immediate early protein. J Biol Chem 273:22075–22082
    [Google Scholar]
  8. Castillo J. P., Yurochko A. D., Kowalik T. F. 2000; Role of human cytomegalovirus immediate-early proteins in cell growth control. J Virol 74:8028–8037
    [Google Scholar]
  9. Chen Z., Knutson E., Kurosky A., Albrecht T. 2001; Degradation of p21cip1 in cells productively infected with human cytomegalovirus. J Virol 75:3613–3625
    [Google Scholar]
  10. DeGregori J., Kowalik T., Nevins J. R. 1995; Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes. Mol Cell Biol 15:4215–4224
    [Google Scholar]
  11. Dittmer D., Mocarski E. S. 1997; Human cytomegalovirus infection inhibits G1/S transition. J Virol 71:1629–1634
    [Google Scholar]
  12. Donnellan R., Chetty R. 1999; Cyclin E in human cancers. FASEB J 13:773–780
    [Google Scholar]
  13. Dulic V., Lees E., Reed S. I. 1992; Association of human cyclin E with a periodic G1–S phase protein kinase. Science 257:1958–1961
    [Google Scholar]
  14. Ekholm S. V., Zickert P., Reed S. I., Zetterberg A. 2001; Accumulation of cyclin E is not a prerequisite for passage through the restriction point. Mol Cell Biol 21:3256–3265
    [Google Scholar]
  15. Fortunato E. A., Sommer M. H., Yoder K., Spector D. H. 1997; Identification of domains within the human cytomegalovirus major immediate-early 86-kilodalton protein and the retinoblastoma protein required for physical and functional interaction with each other. J Virol 71:8176–8185
    [Google Scholar]
  16. Fortunato E. A., McElroy A. K., Sanchez I., Spector D. H. 2000; Exploitation of cellular signaling and regulatory pathways by human cytomegalovirus. Trends Microbiol 8:111–119
    [Google Scholar]
  17. Gebert S., Schmolke S., Sorg G., Floss S., Plachter B., Stamminger T. 1997; The UL84 protein of human cytomegalovirus acts as a transdominant inhibitor of immediate-early-mediated transactivation that is able to prevent viral replication. J Virol 71:7048–7060
    [Google Scholar]
  18. Green S., Issemann I., Sheer E. 1988; A versatile in vivo and in vitro eukaryotic expression vector for protein engineering. Nucleic Acids Res 16:369
    [Google Scholar]
  19. Gribaudo G., Riera L., Lembo D. 8 other authors 2000; Murine cytomegalovirus stimulates cellular thymidylate synthase gene expression in quiescent cells and requires the enzyme for replication. J Virol 74:4979–4987
    [Google Scholar]
  20. Hagemeier C., Caswell R., Hayhurst G., Sinclair J., Kouzarides T. 1994; Functional interaction between the HCMV IE2 transactivator and the retinoblastoma protein. EMBO J 13:2897–2903
    [Google Scholar]
  21. Heider J. A., Bresnahan W. A., Shenk T. E. 2002; Construction of a rationally designed human cytomegalovirus variant encoding a temperature-sensitive immediate-early 2 protein. Proc Natl Acad Sci U S A 99:3141–3146
    [Google Scholar]
  22. Hughes T. A., Cook P. R. 1996; Mimosine arrests the cell cycle after cells enter S-phase. Exp Cell Res 222:275–280
    [Google Scholar]
  23. Jault F. M., Jault J.-M., Ruchti F., Fortunato E. A., Clark C., Corbeil J., Richman D. D., Spector D. H. 1995; Cytomegalovirus infection induces high levels of cyclins, phosphorylated Rb and p53, leading to cell cycle arrest. J Virol 69:6697–6704
    [Google Scholar]
  24. Jiang H., Chou H. S., Zhu L. 1998; Requirement of cyclin E–Cdk2 inhibition in p16(INK4a)-mediated growth suppression. Mol Cell Biol 18:5284–5290
    [Google Scholar]
  25. Kalejta R. F., Shenk T. 2002; Manipulation of the cell cycle by human cytomegalovirus. Front Biosci 7:D295–306
    [Google Scholar]
  26. Koff A., Giordano A., Desai D. 7 other authors 1992; Formation and activation of a cyclin E–cdk2 complex during the G1 phase of the human cell cycle. Science 257:1689–1694
    [Google Scholar]
  27. Kronschnabl M., Marschall M., Stamminger T. 2002; Efficient and tightly regulated expression systems for the human cytomegalovirus major transactivator protein IE2p86 in permissive cells. Virus Res 83:89–102
    [Google Scholar]
  28. Krude T. 1999; Mimosine arrests proliferating human cells before onset of DNA replication in a dose-dependent manner. Exp Cell Res 247:148–159
    [Google Scholar]
  29. Leone G., DeGregori J., Jakoi L., Cook J. G., Nevins J. R. 1999; Collaborative role of E2F transcriptional activity and G1 cyclindependent kinase activity in the induction of S phase. Proc Natl Acad Sci U S A 96:6626–6631
    [Google Scholar]
  30. Lu M., Shenk T. 1996; Human cytomegalovirus infection inhibits cell cycle progression at multiple points, including the transition from G1 to S. J Virol 70:8850–8857
    [Google Scholar]
  31. Lukac D. M., Harel N. Y., Tanese N., Alwine J. C. 1997; TAF-like functions of human cytomegalovirus immediate-early proteins. J Virol 71:7227–7239
    [Google Scholar]
  32. Lukas J., Herzinger T., Hansen K., Moroni M. C., Resnitzky D., Helin K., Reed S. I., Bartek J. 1997; Cyclin E-induced S phase without activation of the pRb/E2F pathway. Genes & Dev 11:1479–1492
    [Google Scholar]
  33. McElroy A. K., Dwarakanath R. S., Spector D. H. 2000; Dysregulation of cyclin E gene expression in human cytomegalovirus-infected cells requires viral early gene expression and is associated with changes in the Rb-related protein p130. J Virol 74:4192–4206
    [Google Scholar]
  34. Marchini A., Liu H., Zhu H. 2001; Human cytomegalovirus with IE-2 (UL122) deleted fails to express early lytic genes. J Virol 75:1870–1878
    [Google Scholar]
  35. Murphy E. A., Streblow D. N., Nelson J. A., Stinski M. F. 2000; The human cytomegalovirus IE86 protein can block cell cycle progression after inducing transition into the S phase of permissive cells. J Virol 74:7108–7118
    [Google Scholar]
  36. Resnitzky D., Gossen M., Bujard H., Reed S. I. 1994; Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol Cell Biol 14:1669–1679
    [Google Scholar]
  37. Rodriguez A., Armstrong M., Dwyer D., Flemington E. 1999; Genetic dissection of cell growth arrest functions mediated by the Epstein–Barr virus lytic gene product, Zta. J Virol 73:9029–9038
    [Google Scholar]
  38. Salvant B. S., Fortunato E. A., Spector D. H. 1998; Cell cycle dysregulation by human cytomegalovirus: influence of the cell cycle phase at the time of infection and effects on cyclin transcription. J Virol 72:3729–3741
    [Google Scholar]
  39. Sauer K., Lehner C. F. 1995; The role of cyclin E in the regulation of entry into S phase. Prog Cell Cycle Res 1:125–139
    [Google Scholar]
  40. Shen Y., Zhu H., Shenk T. 1997; Human cytomagalovirus IE1 and IE2 proteins are mutagenic and mediate “hit-and-run” oncogenic transformation in cooperation with the adenovirus E1A proteins. Proc Natl Acad Sci U S A 94:3341–3345
    [Google Scholar]
  41. Sinclair J., Baillie J., Bryant L., Caswell R. 2000; Human cytomegalovirus mediates cell cycle progression through G1 into early S phase in terminally differentiated cells. J Gen Virol 81:1553–1565
    [Google Scholar]
  42. Song Y. J., Stinski M. F. 2002; Effect of the human cytomegalovirus IE86 protein on expression of E2F-responsive genes: a DNA microarray analysis. Proc Natl Acad Sci U S A 99:2836–2841
    [Google Scholar]
  43. Speir E., Modali R., Huang E.-S., Leon M. B., Shawl F., Finkel T., Epstein S. E. 1994; Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 265:391–394
    [Google Scholar]
  44. Spruck C. H., Won K. A., Reed S. I. 1999; Deregulated cyclin E induces chromosome instability. Nature 401:297–300
    [Google Scholar]
  45. Strohmaier H., Spruck C. H., Kaiser P., Won K. A., Sangfelt O., Reed S. I. 2001; Human F-box protein hCdc4 targets cyclin E for proteolysis and is mutated in a breast cancer cell line. Nature 413:316–322
    [Google Scholar]
  46. Wade M., Kowalik T. F., Mudryj M., Huang E. S., Azizkhan J. C. 1992; E2F mediates dihydrofolate reductase promoter activation and multiprotein complex formation in human cytomegalovirus infection. Mol Cell Biol 12:4364–4374
    [Google Scholar]
  47. Wiebusch L., Hagemeier C. 1999; Human cytomegalovirus 86-kilodalton IE2 protein blocks cell cycle progression in G1 . J Virol 73:9274–9283
    [Google Scholar]
  48. Wiebusch L., Hagemeier C. 2001; The human cytomegalovirus immediate early 2 protein dissociates cellular DNA synthesis from cyclin-dependent kinase activation. EMBO J 20:1086–1098
    [Google Scholar]
  49. Yu Y., Alwine J. C. 2002; Human cytomegalovirus major immediate-early proteins and simian virus 40 large T antigen can inhibit apoptosis through activation of the phosphatidylinositide 3′-OH kinase pathway and the cellular kinase Akt. J Virol 76:3731–3738
    [Google Scholar]
  50. Zhu H., Shen Y., Shenk T. 1995; Human cytomegalovirus IE1 and IE2 proteins block apoptosis. J Virol 69:7960–7970
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.18702-0
Loading
/content/journal/jgv/10.1099/vir.0.18702-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error